Pharma and Healthcare
The pharmaceutical industry is a complex battlefield of strategic interactions between different kinds of players. Issues of high investment uncertainty, especially in (but not restricted to) R&D; strong regulatory influence; the importance of marketing and sales; and the complex interplay of many stakeholders creates tough challenges for executives in the pharmaceutical and healthcare industry.
Our process for the individual modelling of each stakeholder’s interests, combined with our quantitative approach to analyzing strategic interactions, provides suitable support for management decisions in these fields. We have been working in pharmaceuticals and healthcare since 2010.
Aspects we have dealt with in the Pharma and Healthcare industry
Lobbying
Commoditization
Patent expiration
Industry landscaping
Multi-brand strategy
Product substitution
Competitive positioning
Communication strategy
Repositioning strategy
Competitor overreaction
Defending from takeover
New product introduction
Maneuvering in a price war
Attacking the market leader
Using competitor price shield
Handling a dominant competitor
Reaction to patent infringement
Avoiding head-to-head competition
Handling an aggressive competitor
Market exit and pullback strategy
Regulatory strategy and approvals
Sales force allocation and budgeting
Competitive pricing: dynamic strategy
Product development and specification
Responding to a competitor’s new product
Product / technology licensing agreement
Defense / counter strategy against competitor move
Strategic market positioning and market segmentation
Competitor acquisition: assessing the implications for competitive dynamics
Negotiation strategy, preparation, and support / multiple party negotiation
Strategic alliances, joint ventures, and partnering: forming and ending them